Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review
R. E. Kalinin,
E. P. Kulikov,
N. I. Verkin,
S. A. Mertsalov,
E. Yu. Golovkin,
I. N. Shanaev,
O .V. Zotova https://doi.org/10.18699/SSMJ20240501
Abstract
Interventional oncology is a rapidly evolving field of cancer treatment. Minimally invasive techniques, such as transarterial embolization with chemotherapeutic and radioactive agents, are common treatments and are found in many guidelines for the treatment of primary and metastatic liver lesions. It is known that the growth and development of a malignant neoplasm is primarily determined by angiogenesis. Rapid growth is ensured where the formation is directly related to the arterial bed. Therefore, when the drug is injected into the target vessel and providing tissue ischemia, it is possible to achieve a high degree of tumor pathomorphosis. This technique has an advantage for patients who, in some cases, cannot be treated surgically, and also increases the effectiveness of the chemotherapeutic effect. With the advent of necessary equipment in hospitals and the accumulation of experience in the use of minimally invasive interventions, it became possible to implement a new method of treating tumors of various localizations. In this review, we consider the results of domestic and foreign authors on the topic of intra-arterial chemoembolization before surgical treatment in patients with rectal cancer. It is noted that the analysis of the literature revealed a small number of works devoted to the chosen topic, despite the relevance of this problem for modern oncology.
About the Authors
R. E. Kalinin
Ryazan State Medical University named after Academician I.P. Pavlov of Minzdrav of Russia
Russian Federation
Russian Federation
Roman E. Kalinin, doctor of medical sciences, professor
390026 Ryazan, Vysokovoltnaya st., 9
E. P. Kulikov
Ryazan State Medical University named after Academician I.P. Pavlov of Minzdrav of Russia ; Ryazan Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
Evgenyi P. Kulikov, doctor of medical sciences, professor
390026 Ryazan, Vysokovoltnaya st., 9
390011, Ryazan, Sportivnaya st., 13
N. I. Verkin
Ryazan Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
Nicolay I. Verkin, candidate of medical sciences
390011, Ryazan, Sportivnaya st., 13
S. A. Mertsalov
Ryazan State Medical University named after Academician I.P. Pavlov of Minzdrav of Russia ; Ryazan Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
Sergey A. Mertsalov, candidate of medical sciences
390026 Ryazan, Vysokovoltnaya st., 9
390011, Ryazan, Sportivnaya st., 13
E. Yu. Golovkin
Ryazan State Medical University named after Academician I.P. Pavlov of Minzdrav of Russia ; Ryazan Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
Evgenyi Yu. Golovkin, candidate of medical sciences
390026 Ryazan, Vysokovoltnaya st., 9
390011, Ryazan, Sportivnaya st., 13
I. N. Shanaev
Ryazan State Medical University named after Academician I.P. Pavlov of Minzdrav of Russia ; Ryazan Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
Ivan N. Shanaev, doctor of medical sciences
390026 Ryazan, Vysokovoltnaya st., 9
390011, Ryazan, Sportivnaya st., 13
O .V. Zotova
Ryazan State Medical University named after Academician I.P. Pavlov of Minzdrav of Russia
Russian Federation
Russian Federation
Olga V. Zotova
390026 Ryazan, Vysokovoltnaya st., 9
References
1. Kaprin A.D., Starinsky V.V., Shakhzadova A.O. The state of cancer care for the population of Russia in 2022. Moscow, 2022. 239 p. [In Russian].
2. Arnold M., Sierra M.S., Laversanne M., Soer-jomataram I., Jemal A., Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683−691. doi: 10.1136/gutjnl-2015-310912
3. O’Leary C., Soulen M.C., Shamimi-Noori S. Interventional oncology approach to hepatic metastases. Semin. Intervent. Radiol. 2020;37(5):484−491. doi: 10.1055/s-0040-1719189
4. Tarazov P.G. Tumors of the stomach and intestines. In: Interventional radiology in oncology (paths of development and technology). Saint-Petersburg: Foliant, 2007. Р. 275−281. [In Russian].
5. Chissov V.I., Vashakmadze L.A., Daryalova S.L. Combined treatment of rectal cancer. Rossiyskiy onkologicheskiy zhurnal = Russian Journal of Oncology. 1998;(6):9−12. [In Russian].
6. Vorobyov G.I., Kuzminov A.M., Korotkikh N.N., Popov R.V., Olshansky M.S. Combined endovascular and surgical management of low ampular rectal cancer. Vestnik eksperimental’noy i klinicheskoy khirurgii = Journal of Experimental and Clinical Surgery. 2011;4(1):162−167. [In Russian].
7. Guide to operative oncology. Eds. F.K. Wright, J.M. Escallon. Moscow: GeotarMedia, 2023. 616 p. [In Russian].
8. Berdov B.A., Nevolskikh A.A., Titova L.N. Resectable rectal cancer and radiation therapy. Khirurgia = Surgery. 2014;(5):84−91. [In Russian].
9. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., Putter H., Steup W.H., Wiggers T., Rutten H.J., Pahlman L., Glimelius B., van Krieken J.H., … Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 2001;345(9):638−646. doi: 10.1056/NEJ-Moa010580
10. van Gijn W., Marijnen C.A., Nagtegaal I.D., Kranenbarg E.M., Putter H., Wiggers T., Rutten H.J., Pahlman L., Glimelius B., van de Velde C.J.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12- year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575−582. doi: 10.1016/S1470-2045(11)70097-3
11. Petrelli F., Sgroi G., Sarti E., Barni S. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer: a meta-analysis of published studies. Ann. Surg. 2016; 263(3):458−464. doi: 10.1097/SLA.0000000000000368
12. Feeney G., Sehgal R., Sheehan M., Hogan A., Regan M., Joyce M., Kerin M. Neoadjuvant radiotherapy for rectal cancer management. World J. Gastroenterol. 2019;25(33):4850−4869. doi: 10.3748/wjg.v25.i33.4850
13. Maistrenko N.A., Galkin V.N., Erygin D.V., Sazonov A.A. Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer. Vestnik khirurgii imeni Ivana Ivanovicha Grekova = Grekov’s Bulletin of Surgery. 2017;176(4):31−38. [In Russian].
14. Lorimer P.D., Motz B.M., Kirks R.C., Boselli D.M., Walsh K.K., Prabhu R.S., Hill J.S., Salo J.C. Pathologic complete response rates after Neoadjuvant treatment in rectal Cancer: An analysis of the National Cancer Database. Ann. Surg. Oncol. 2017;24(8):2095−2103. doi: 10.1245/s10434-017-5873-8
15. Sauer R., Becker H., Hohenberger W., Rödel C., Wittekind C., Fietkau R., Martus P., Tschmelitsch J., Hager E., Hess C.F., … German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 2004;351(17):1731−1740. doi: 10.1056/NEJMoa040694
16. Frykholm G.J., Påhlman L., Glimelius B. Combined chemoand radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum. Int. J. Radiat. Oncol. Biol. Phys. 2001;50(2):427−434. doi: 10.1016/s0360-3016(01)01479-1
17. Probst C.P., Becerra A.Z., Aquina C.T., Tejani M.A., Wexner S.D., Garcia-Aguilar J., Remzi F.H., Dietz D.W., Monson J.R., Fleming F.J.; Consortium for Optimizing the Surgical Treatment of Rectal Cancer (OS-TRiCh). Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation. J. Am. Coll. Surg. 2015;221(2):430−440. doi: 10.1016/j.jamcoll-surg.2015.04.010
18. Sun Z., Adam M.A., Kim J., Shenoi M., Migaly J., Mantyh C.R. Optimal timing to surgery after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J. Am. Coll. Surg. 2016; 222(4):367−374. doi: 10.1016/j.jamcollsurg.2015.12.017
19. Zaharchenko A.A., Protopopov A.V., Vinnik Yu.S., Litvinyuk N.V. Endovascular interventions in combined treatment of patients with rectal cancer. In: Interventional radiology in oncology. National guidelines. Vol. 1. Ed. B.I. Dolgushin. Moscow: Vidar-M, 2022. Р. 703−722. [In Russian].
20. Zakharchenko A.A. Comparative results of preoperative oil chemoembolization of rectal arteries in the combined treatment of resectable rectal cancer. Koloproktologiya = Coloproctology, 2018;(2):59−67. [In Russian].
21. Kalinin R.E., Suchkov I.A., Alferov Yu.V., Karpov A.V., Shanaev I.N. Coronary artery aneurism: a clinical case. Nauka molodykh = Eruditio Juvenium. 2021;9(4):605–612. [In Russian]. doi: 10.23888/HMJ202193605-612
22. Kalinin R.E., Suchkov I.A., Shanaev I.N., Agapov A.B., Khashumov R.M. Case report of patient with posttraumatic arteriovenous fistula of femoral vessels in the lower third of thigh: peculiarities of pathogenesis and difficulties of management. Rossiyskiy mediko-biolo-gicheskiy vestnik imeni akademika Ivana Petrovicha Pavlova = I.P. Pavlov Russian Medical Biological Herald. 2022;30(3):375−386. [In Russian]. doi: 10.17816/PAVLOVJ102594
23. Song J., Chen W., Zhu X., Zhao Z., Chen M., Huang L., Tu J., Zhou H., Zhou L., Ji J. Short-term efficacy, safety, and cost-effectiveness of transarterial chemoembolization with drug-eluting beads versus synchronous radiochemotherapy for cervical cancer. Int. J. Gynaecol. Obstet. 2019;147(1):29−35. doi: 10.1002/ijgo.12888
24. Babaeva N.A., Antonova I.B., Aleshikova O.I. The role of selective chemoembolization of the uterine arteries in the complex treatment of locally advanced cervical cancer. Doktor.Ru = Doctor.Ru. 2018;(2):20−25. [In Russian].
25. Tian Z.Z., Li S., Wang Y., Yue Y.J., Zhu X.H., Zhao R., Zhang C.L., Wei S.H. Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study. Arch. Gynecol. Obstet. 2014;290(1):155−162. doi: 10.1007/s00404-014-3166-z
26. Kucherov V.V., Danilenko S.Yu., Krikunova L.I., Trifonov F.A., Petrosyan A.P., Nadinsky D.O. Chemoembolization of uterine arteries in treatment of cervical cancer (literature review). Diagnosticheskaya i interventsionnaya radiologiya = Diagnostic and Interventional Radiology. 2020;14(3):46−55. [In Russian]. doi: 10.25512/DIR.2020.14.3.05
27. Petrosyan A.P., Kucherov V.V., Trifonov F.A., Nadinsky D.O. Hepatic chemoembolization for hepatocellular carcinoma and metastatic colorectal cancer. Mezhdunarodnyy zhurnal interventsionnoy kardioangiologii = International Journal of Interventional Cardioangiology. 2019;(56/57):27−40. [In Russian].
28. Olshansky M.S., Glukhov A.A., Zhdanov A.I., Korotkikh N.N., Evteev V.V. Rationale for the feasibility of endovascular treatment of rectal cancer. Vestnik eksperimental’noy i klinicheskoy khirurgii = Journal of Experimental and Clinical Surgery. 2012;5(4):644–647. [In Russian].
29. Zakharchenko M.A., Kirichenko A.K., Shtoppel A.E. Intrapelvic dissemination of tumor complexes in combined treatment of rectal cancer using X-ray endovascular interventions. Current problems of coloproctolog: proc. conf., Moscow, February 2–4, 2005. Moscow: Medpraktika-M, 2005. Р. 326–328. [In Russian].
30. Ensminger W.D., Gyves J.W. Regional chemotherapy of neoplastic diseases. Pharmac. Ther. 1983;21(2):277−293. doi: 10.1016/0163-7258(83)90077-3
31. Vogel A., Cervantes A., Chau I., Daniele B., Llovet J.M., Meyer T., Nault J.C., Neumann U., Ricke J., Sangro B., … ESMO Guidelines Committee. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2018;29(Suppl 4):iv238−iv255. doi: 10.1093/annonc/mdy308
32. Breuer J.A., Ahmed K.H., Al-Khouja F., Macherla A.R., Muthoka J.M., Abi-Jaoudeh N. Interventional oncology: new techniques and new devices. Br. J. Radiol. 2022;95(1138):20211360. doi: 10.1259/bjr.20211360
33. European Association for the Study of the Liver; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018;69(1):182–236. doi: 10.1016/j.jhep.2018.03.019
34. Affonso B.B., Galastri F.L., da Motta Leal Filho J.M., Nasser F., Falsarella P.M., Cavalcante R.N., de Almeida M.D., Felga G.E.G., Valle L.G.M., Wolosker N. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging. World J. Gastroenterol. 2019;25(37):5687–5701. doi: 10.3748/wjg.v25.i37.5687
35. Marrero J.A., Kulik L.M., Sirlin C.B., Zhu A.X., Finn R.S., Abecassis MM., Roberts L.R., Heimbach J.K. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases. Hepatology. 2018;68:723–750. doi: 10.1002/hep.29913
36. Olshansky M.S., Korotkikh N.N. A method for endovascular treatment of locally advanced rectal cancer complicated by colonic obstruction. Patent 2469658 RF; published 12.20.2012. [In Russian].
37. Korotkikh N.N., Zhdanov A.I., Olshansky M.S., Kazarezov O.V. Role of sacral arteries in rectum blood supply. Vrach-aspirant = Postgraduate Doctor. 2013;61(6.1):165−170. [In Russian].
38. Zhdanov A.I., Kazarezov O.V., Olshansky M.S., Korotkikh N.N. Role of middle rectal artery in rectum bloods supply. Fundamental’nye issledovaniya = Fundamental Research. 2014;10(1):70−75. [In Russian].
39. Olshansky M.S., Korotkikh N.N., Kazarezov O.V. Clinical value of anastomosis between middle rectal and uterine arteries in endovascular interventions. Meditsinskiy vestnik Yuga Rossii = Medical Herald of the South of Russia. 2015;(4):68−71. [In Russian].
40. Korotkikh N.N., Olshansky M.S., Kazarezov O.V. Anatomo-angiographic features of rectum blood supply and their clinical significance. Koloproktologiya = Coloproctology. 2016;(3):31−36. [In Russian].
41. Olshansky M.S., Korotkikh N.N. Immediate and fiveyear results of application of preoperative oily chemoembolization of rectal arteries in complex treatment of the loco-regional rectal cancer. Vestnik khirurgii imeni Ivana Ivanovicha Grekova = Grekov’s Bulletin of Surgery. 2013;172(1):34−37. [In Russian].
42. Olshansky M.S., Korotkikh N.N., Evteev V.V. Immediate and long term results of selective lipoidol oil chemoembolization of rectal arteries and surgery in combined management of rectal carcinomas. Fundamental’nye issledovaniya = Fundamental Research. 2012;(2-2):321−324. [In Russian].
43. Olshansky M.S., Korotkikh N.N., Ponamareva E.N., Kazarezov O.V. Endovascular treatment of locally-advanced rectal carcinoma considering specific features of blood supply of rectum (the review of literature and own observations). Onkologicheskaya koloproktologiya = Oncological coloproctology. 2013;(1):29−34. [In Russian].
44. Korotkikh N.N., Olshansky M.S. Mid-term results of combined endovascular and surgical treatment of cancer of the rectum. Rossiyskiy mediko-biologicheskiy vestnik imeni akademika Ivana Petrovicha Pavlova = I.P. Pavlov Russian Medical Biological Herald. 2011;19(3):87−92. [In Russian].
45. Korotkikh N.N., Brezhnev S.G., Korotkikh K.N. Selective endovascular oil embolization in the complex treatment of complicated rectal cancer. Koloproktologiya = Coloproctology, 2019;18(S3):89−94. [In Russian].
46. Korotkikh N.N., Olshansky M.S., Timoshin I.S. Simultaneous selective transcatheter oil chemoembolization of arteries rectalis superior, medial and inferior in the complex treatment of rectal cancer. Sistemnyy analiz i upravleniye v biomeditsinskikh sistemakh = System Analysis and Control in Biomedical Systems. 2009;8(4):1078−1082. [In Russian].
47. Korotkikh N.N. First line surgical rehabilitation of the patients with low ampular rectal cancer. Sistemnyy analiz i upravleniye v biomeditsinskikh sistemakh = System Analysis and Control in Biomedical Systems. 2009;8(4):1093−1099. [In Russian].
48. Korotkikh N.N., Olshansky M.S., Ektov V.N. The application of selective chemoembolization of arteries rectalis at treating rectal cancer. Vestnik novykh meditsinskikh tekhnologiy = Journal of New Medical Technologies. 2011;18(2):352–355. [In Russian].
49. Moshurov I.P., Zhdanov A.I., Olshansky M.S., Kazarezov O.V., Korotkikh N.N., Popov R.V. The role of interventional surgical methods in the combined treatment of rectal cancer. Koloproktologiya = Coloproctology. 2014;(S3):71−72. [In Russian].
50. Zubarev P.N., Alentyev S.A., Kotiv B.N., Litvinov O.A., Soloviev I.A., Dzidzava I.I., Lazutkin M.V., Ignatovich I.G. Method of combined treatment of cancer of the left half of the colon and upper ampullary rectum. Patent 2358660 RF; published 06.20.2009. [In Russian].
51. Odaryuk T.S., Olshansky M.S., Korotkikh N.N., Timoshin I.S., Evteev V.V. Selective oil chemoembolization of rectal arteries in the complex treatment of locally advanced rectal cancer. Diagnosticheskaya i interventsionnaya radiologiya = Diagnostic and Interventional Radiology. 2009;3(3):85−87. [In Russian].
52. Peng S.H., Mbarak H.S., Li Y.H., Ma C., Shang Q.L., Chen Z., Bian D.J., Xiao E.H. Neoadjuvant intra-arterial versus intravenous chemotherapy in colorectal cancer. Medicine (Baltimore). 2021;100(51):e28312. doi: 10.1097/MD.0000000000028312
53. Yang B., Shan J., Feng Y., Dai N., Li M., Chen C., He S., Wang G., Xiao H., Li C., Wang D. Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study. Radiat. Oncol. 2020;15(1):94. doi: 10.1186/s13014-020-01540-4
54. Secco G.B., Fardelli R., Campora E., Sertoli M.R., de Caro G., Cariati A., Zoli S., Gianquinto D. Preoperative intra-arterial mitomycin-C in the management of sigmoid adenocarcinoma: long-term results of a pilot study. Tumori. 1994;80(5):339−343. doi: 10.1177/030089169408000505
55. Gu J., Peng Y., Ma Z., Leng X., Wang Y., Xu G. Long-term results of preoperative regional intraarterial chemotherapy against colorectal cancer. Zhonghua Wai Ke Za Zhi. 2002;40(6):404−406.
56. Huang W., Huang P., Guo H., Huang Z., Wei M., Guo J., Lin C., Li Y., Luo B., Lin J., Wang L. Single-arm, phase II study of intra-arterial chemotherapy plus total neoadjuvant therapy to optimise complete response in distal rectal cancer: a study protocol. BMJ Open. 2023;13(10):e075023. doi: 10.1136/bmjopen-2023-075023
57. Babaei M., Jansen L., Balavarca Y., Sjovall A., Bos A., van de Velde T., Moreau M., Liberale G., Gonçalves A.F., Bento M.J., … Brenner H. Neoadjuvant therapy in rectal cancer patients with clinical stage II to III across European countries: variations and outcomes. Clin. Colorectal Cancer 2018;17(1):129‒142. doi: 10.1016/j.clcc.2017.09.002
58. Vodenkova S., Buchler T., Cervena K., Veskrnova V., Vodicka P., Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol. Ther. 2020;206:107447. doi: 10.1016/j.pharmthera.2019.107447
59. Sethy C., Kundu C.N. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed. Pharmacother. 2021;137:111285. doi: 10.1016/j.biopha.2021.111285
60. Alzahrani S.M., Al-Doghaither H.A., Al-Ghafari A.B., Pushparaj P.N. 5-Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review). Oncol. Rep. 2023;50(4):175. doi: 10.3892/or.2023.8612
61. Vidal 2022. Medicines in Russia. Vidal Rus, 2022;1120. [In Russian].
62. Zhu A.X., Willett C.G. Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer. Radiat. Oncol. 2003;13(4):454−468. doi: 10.1016/S1053-4296(03)00048-1
63. Hill E.J., Nicolay N.H., Middleton M.R., Sharma R.A. Oxaliplatin as a radiosensitiser for upper and lower gastrointestinal tract malignancies: what have we learned from a decade of translational research? Crit. Rev. Oncol. Hematol. 2012;83(3):353−387. doi: 10.1016/j.critrevonc.2011.12.007
64. Milas L., Mason K.A., Liao Z., Ang K.K. Chemoradiotherapy: emerging treatment improvement strategies. Head Neck. 2003;25(2):152−167. doi: 10.1002/hed.10232
65. Amorino G.P., Freeman M.L., Carbone D.P., Lebwohl D.E., Choy H. Radiopotentiation by the oral platinum agent, JM216: role of repair inhibition. Int. J. Radiat. Oncol. Biol. Phys. 1999;44(2):399−405. doi: 10.1016/s0360-3016(99)00033-4
66. Baker D.E. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum. Rev. Gastroenterol. Disord. 2003;3(1):31−38.
67. Wilkes G.M. New therapeutic options in colon cancer: focus on oxaliplatin. Clin. J. Oncol. Nurs. 2002;6(3):131−137. doi: 10.1188/02.CJON.131-137
68. Cividalli A., Ceciarelli F., Livdi E., Altavista P., Cruciani G., Marchetti P., Danesi D.T. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int. J. Radiat. Oncol. Biol. Phys. 2002;52(4):1092−1098. doi: 10.1016/s0360-3016(01)02792-4
Review
For citations:
Kalinin R.E., Kulikov E.P., Verkin N.I., Mertsalov S.A., Golovkin E.Yu., Shanaev I.N., Zotova O... Intra-arterial chemoembolization as a component of neoadjuvant treatment of rectal cancer. Literature review. Сибирский научный медицинский журнал. 2024;44(5):6-18. (In Russ.) https://doi.org/10.18699/SSMJ20240501
Views:
1016
Email this article 